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2ABSTRACT
Skeletal myofibers differentiated from primary avian myoblasts
in tissue culture can be maintained in positive nitrogen balance
in a serum-free medium for at least 6-7 days when embedded in a
three dimensional collagen gel matrix. The myofibers are
metabolically sensitive to physiological concentrations of insulin
(10 "11 to 10"I° M) but these concentrations do not stimulate cell
growth. Higher insulin concentrations (5 x i0-' to i0 -_ M) stimulate
both cell hyperplasia and myofiber hypertrophy. Cell growth results
from a long term 42% increase in total protein synthesis (P < .001)
and a 38% decrease in protein degradation (P < .001). Myofiber
diameters increase by 71% to 98% after 6-7 days in insulin-
containing medium (P< .001). Insulin-like growth factor-i but not
insulin-like growth factor-2, at 250 ng/ml, is as effective as
insulin in stimulating cell hyperplasia and myofiber hypertrophy.
This model system provides a new method for studying the loDg-term
anabolic effects of insulin and insulin-like growth factors on
myofiber hypertrophy under defined tissue culture conditions.
Index Terms: Insulin; Insulin-like Growth Factors; Skeletal Muscle;
Hypertrophy; Hyperplasia: Protein Synthesis; Protein Degradation.
3INTRODUCTION
Insulin is a potent anabolic growth factor for skeletal
muscle. Although this polypeptide hormone has been extensively
studied for many years, the molecular events coupling insulin
receptor binding to myofiber growth are still unclear (18).
Experiments involving insulin-induced muscle growth in vivo are
complicated by the nature of whole animal studies. Organ culture
muscle studies are limited to short time periods during which the
tissue is in negative nitrogen balance (2). Tissue cultured
skeletal muscle cells hive been extensively used to study the
effects of insulin and insulin-like growth factors on myogenic cell
proliferation and differentiation (8,9). Studies of the effects of
these growth factors on subsequent myofiber growth in tissue
culture have been limited by the inability to maintain
differentiated myofibers for extended periods of time in serum
free, defined media (I,I0,13). We recently reported a new protocol
for maintaining differentiated, highly contractile avian myofibers
under tension in serum-free medium for up to 14 days (27). This
method involves embedding the newly developed myotubes in a three
dimensional collagen gel matrix attached to a stainless steel
support structure. These cells differentiate into well-striated,
neonatal-like myofibers. We now describe a muscle maintenance
medium in which insulin and insulin-like growth factor-i induce
rapid and pronounced skeletal myofiber hypertrophy over a period
of days. This system provides a new method for studying the long
term anaOolic effects of insulin-like growth £actors on skeletal
muscle hypertrophy under defined culture conditions. In addition,
4it will allow the in vitro analysis of the complex interactions of
growth factors and muscle mechanical activity which synergistically
regulate skeletal muscle growth both in vivo (7,15) and in vitro
(24,26). Parts of this work have appeared in abstract form (25).
MATERIALS AND METHODS
Cell Cultures
Avian myoblasts are isolated from ii to 12 days in ovo
pectoralis muscle by standard dissection techniques (27).
Fertilized chicken eggs are obtained from Beaver River Farm (West
Kingston, RI). The cells are plated at a very high density of 5,700
cells/mm 2 in 1 ml of growth medium and maintained in a humidified
5.0% CO2 incubator at 37°C. Growth medium is Eagle's basal medium
containing 50 U/ml penicillin (Sigma Chemical, St. Louis, MO), 10%
horse serum (Hyclone Laboratories, Logan, UT), and 5% chicken
embryo extract (85/10/5 medium). Cells are plated and grown in
collagen-coated 15 mm diameter tissue culture dishes (Nunc Corp.,
Roskilde, Denmark). At 48-54 h postplating, the cells are embedded
in a collagen gel matrix (27). Briefly, the culture medium is
removed and 0.5 ml of ice-cold collagen solution is added_ The
collagen solution is prepared immediately before use by mixing
85/10/5 medium with rat tail collagen (Type I, Collaborative
Research, Bedford, MA) to a final concentration of 200-400 _g/0.5
ml. Sterile sodium hydroxide (0.1N) is added to the chilled
solution to maintain a pH of 7.0. Stainless steel wire cloth (mesh
no. 50, Newark Wire Cloth, Newark, NJ) is placed inside the
perimeter of each well immediately after the collagen gel solution
is added to the wells but before polymerization. The screen acts
as an "artificial tendon" by providing a surface to which the
differentiating cells and collagen gel can attach and be held under
tension during long-term growth in defined medium. Culture medium
(85/10/5) is added to the top of the hardened collagen gel 24 h
after solidifying and changed every 24 h thereafter. After several
6days, the collagen gel dehydrates, collapsing on top of the muscle
cells as a thin 12-50 _m layer (27) in the same manner as described
for other cell types (3). Under these growth conditions, the
myogenic cells proliferate and fuse during the first 24 to 72 h in
vitro, become striated and highly contractile by 96 to 120 h, and
remain so for the duration of the experiments. Day 6 to Day 8
postplating cultures contain 30-40% of their nuclei in
mononucleated cells, the majority of which are fibroblasts. Eighty-
five to ninety percent of the noncollagenous protein in the
cultures is located in the much larger multinucleated skeletal
myofibers based on morphometric analysis of cell volumes (26).
On Day 6-8 postplating, the cultures are rinsed over a 2 h
period with Eagle's basal medium containing 50 U/ml penicillin (i
ml/well, 6 x 15 min changes) on a rotary shaker (60 rpm) at 37°C.
Serum-free muscle maintenance medium (mm medium) is added to the
cultures (500 _i/well) containing varying concentrations of bovine
insulin (Sigma Chemical Co. cat. no. I1882, 24.5 IU/mg protein),
insulin-like growth factor-i (Collaborative Research hIGF-I,
Bedford MA), or insulin-like growth factor-2 (MSA, Collaborative
Research). MM medium is Eagle's basal medium containing 1,250 mg/l
bovine serum albumin (Sigma Chemical Co. cat. no. A4161), 0.05 mg/l
sodium selenite (Sigma Chemical Co. cat. no. S0882), 0.835 mg/l
ferrous sulfate (Sigma Chemical Co. cat. no. F8633), 5.0 mg/l
linoleic acid (Sigma Chemical Co. cat. no. LI012), and 50 IU/ml
penicillin. All reagents are cell culture tested by Sigma. The
medium is changed every 24 h for the duration of each experiment.
Biochemical Assays
Glucose utilization by the cells is measured as the
disappearance of glucose from the culture medium. One ml fresh mm
medium with or without growth factors is added to each culture well
and changed at 4-6 h intervals. The cultures are maintained in a
37°C C02 incubator on a rotary shaker (60 rpm) during the
incubation. The glucose level in the medium is measured with a YSI
Glucose/Lactate Analyzer, Model 2000. The reduction in glucose
during the 4-6 h incubation is calculated from the difference in
medium glucose content relative to medium incubated at 37°C without
cells.
Protein synthesis is measured as L-[U-1'C]-phenylalanine
(Amersham, Arlington Heights, IL) incorporated into trichloroacetic
acid-insoluble material during a 4 h incubation period in the
presence of 0.6 mM nonradioactive phenyla!anine as previously
outlined (26). Incorporation of 14--C--phenlyalanine is linear during
this time period (26). Results are expressed as DPMs incorporated
per ug total noncollagenous protein. This assay method does not
give absolute rates of protein synthesis since the specific
radioactivity of the charged-tRNA precursor pool is not directly
measured. But the method gives accurate relative rates of protein
synthesis since the specific radioactivity of charged-tRNA pools
in cultured muscle cells are not altered by insulin or insulin-like
growth factors (I,i0). Aliquots from sonicated samples are also
analyzed for total noncollagenous protein, and total DNA content
by previously described procedures (26).
8Protein degradation rates of long lived proteins are measured
by an intermittent perfusion technique. Its validation as an
accurate measure of total protein degradation in tissue cultured
skeletal muscle cells has been described previously (28). Briefly,
cellular proteins are labelled by incubation of the cells in medium
containing 0.5 to 1.0 _Ci/ml L-[U-_'C] phenylalanine for 20-24 h at
37°C. The cells are rinsed with Eagle's basal medium containing 25
mM Hepes (pH 7.4) and 1.0 mM nonradioactive phenylalanine. The
cultures are shaken for 2 h at 37°C on a rotary shaker (60 rpm) and
the rinse medium changed 3 times to remove unincorporated
radioactivity. One ml of fresh medium is added and rotary shaking
of the culture dishes is continued at 37°C during the entire assay
period. The efflux of trichloroacetic acid soluble radioactivity
into the medium is followed for 1 to 32 h. Calculation of the
percent radioactivity remaining in protein at each time point and
protein half-lives are performed as previously described (28).
Excess nonradioactive phenylalanine (I.0 mM) in the medium during
the degradation assay period prevents significant reutilization cf
_'-C-phenylalanine (28). Comparison of protein degradation rates
obtained with this intermittent perfusion technique to one using
a nonreutilizable amino acid (2-_H-phenylalani ne) indicates that
reutilization of radioactive phenylalanine released from prelabeled
proteins is not a complicating factor in the measurement of protein
degradation rates in cultured muscle cells (29).
Morphometry
To visualize the mycfiberc, the cells are stained by an enzyme
immunocytochemical technique. A monoclonal antibody specific for
9avian embryonic fast-myosin heavy chain (EBI65) is used (4)
together with an avidin-biotinylated secondary antibody reaction
coupled to horseradish peroxidase (Vectastain ABC, Vector
Laboratories, Burlingame, CA). The stained cells are embedded in
Spurr embedding medium (Polysciences, King of Prussia, PA) and
observed as whole mounts or thin sections with a light microscope
(xl0 to xl00 oil immersion objectives, total magnification x125 to
x1250). Microscopic fields are observed using a Zeiss microscope
equipped with a drawing tube attachment focused onto a Numonics
2210 digitizing tablet that is connected to a Compaq Deskpro 286
computer. The stained cells and tablet mouse can be seen while
looking through the microscope eyepieces. Morphological
measurements are made using morphometry software (SIGMA SCAN,
Jandel Scientific, Sausalito, CA) and all data are computer
corrected i'or magnification. Mean myofiber diameters are measured
on randomly selected whole mount and thin section fields. In whole
mounts, the length and area of each myofiber in the field are
measured and the mean diameter calculated. In thin sections, the
diameter of each myotube in the field is measured 3-4 times at
different points around the cell's circumference, and the minimal
value used as the cell's diameter. As outlined previously, both
methods give similar results C26).
Statistical analyses of the data are performed by t-tests for
paired and unpaired values (PC Statistician Software, Human Systems
Dynamics, Northridge, CA).
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RESULTS
Primary avian muscle cells cultured for 7-14 days embedded in
a three dimensional collagen gel matrix are highly contractile and
morphologically well differentiated with several characteristics
of neonatal myofibers, including a well developed external lamina
layer and well organized myofibrils (27). Sixty to eighty percent
of these myofibers stain positive for the neonatal isoform of
myosin heavy chain _• The collagen embedded myofibers are
structurally stronger than non-collagen embedded myofibers, based
on their ability to withstand repetitive mechanical stimulation for
several days without rupturing (26). The myofibers can be
maintained for several weeks under tension in unsupplemented medium
(27). Myofiber cell densities remain constant under these culture
conditions.
Addition of physiological concentrations of insulin (I0 -_ to
i0 -_° M) to the Day 7-Day 8 cultures in mm medium stimulates glucose
utilization by 42-54% during the first 4 h after its addition
(Figure i, Insert). Glucose utilization returns to control levels
after this time period in i0 -_I to I0 -_ M (data not shown).
Increasing the insulin concentration to i0 -_ M or greater produces
a longer term increase in glucose utilization which can be measured
over a 24 h period. Insulin concentration of approximately I0 °_ M
produces a secondary increase in glucose utilization and this
increase is also maintained for at least 24 h (Figure i, Main
Graph).
Supraphysiological insulin concentrations (i0-to I0 -_ M) also
stimulate nonco].!agenous protein and DNA acclmu]ation in the
_D
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cultures after two to three days of incubation (Figure 2),
indicating an anabolic response of the cells to high insulin
concentrations. Physiological concentrations of insulin are
ineffective in stimulation of either protein or DNA accumulation
in the cultures (Figure 2). Similar results were obtained in two
additional experiments (data not shown). The cells' anabolic
response to high insulin concentrations (based on total
noncollagenous protein accumulation) occurs in muscle cultures 7
to i0 days postplating, and the response does not increase in older
cultures (Table i). Insulin stimulation of cell proliferation is
significantly greater 7 to i0 days postplating than 13 to 16 days
postplating, when control culture DNA content is almost twice that
of Day 7 to i0 cultures (Table i).
Cultures treated with high insulin concentrations for 5 days
have larger diameter myotubes than myotubes in unsupplemented
medium (Figure 3). It is eviden_ from Figure 3C that cells
incubated for 5 days in unsupplemented mm medium are structurally
well maintained. Many of the myotubes increase to 20 to 40 _m in
diameter after 5 to 7 days in the presence of insulin. Mean
myofiber diameter increases 98% (P < .001) with 6-7 days of
incubation in i0 -° M insulin (Day 7 to Day 14 postplating) and 78%
(P < .001) for Day 14 to Day 19 postplating cultures (Figure 4).
Myofibers diameters are 20-38% (P < .01) greater in insulin
containing mm medium than in cultures supplemented with 10% serum
and 5% embryo extract during this time period (Figure 4). Insulin
at high levels thus induces rapid and [_ronounced _K_loral myofiO_r
hypertrophy in defined mm medium.
r-_
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From 1 to 6 days of incubation of Day 7 to 8 postplating
muscle cultures in mm medium without insulin there is a small,
nonsignificant 9.5% decrease in protein synthesis rates and a
significant, 21% (P < .001) increase in protein degradation rates
compared to cultures incubated in complete 85/10/5 medium (data not
shown). Insulin at i0-' to 10 .5 M stimulates protein synthesis rates
by 22% to 41% (P < .001) after either 3 days (Figure 5A) or 6 days
of incubation (Figure 5B). Insulin at i0 -6 M concentration reduces
total protein degradation rates by 36-39% (P < .001) after either
1 day (Figure 6A) or 6 to 7 days of incubation (Figure 6B), based
on calculation of mean protein half lives from the slopes of the
degradation rates shown in Figure 6. During the first day of
incubation in mm medium with insulin, protein degradation is
reduced to a level similar to that seen in 85/10/5 medium (Figure
6A). Insulin is less effective than 85/10/5 in reducing protein
degradation over 6 days cf incubation (Figure 6B). Insulin thus
stimulates cell growuh by a long term stimulation of protein
synthesis rates and inhibition of protein degradation rates.
Insulin-like growth factor-i (IGF-I) and insulin-like growth
factor-2 (multiplication stimulating activity, IGF-2) also
stimulate noncollagenous protein and DNA accumulation in skeletal
muscle cultures after 3 days of incubation in mm medium (Figure 7).
IGF-I is a more potent stimulator of cell growth than IGF-2,
significantly stimulating noncollagenous protein accumulation at
a lO-fold lower concentration than IGF-2 and to a 2.2 greater
_._n_ at _e hl_i,e_'__ concentration _t _........ - _ v i0 -_ g/ml (_iqure_
7A). IGF-I significantly stimulates DNA accumulation at a 50 x
o_
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lower concentration than IGF-2 and to a 1.4 x greater extent than
IGF-2 at 5 x 10 .7 g/ml (Figure 7B).
Microscopic analysis of Day 7 to 12 postplating cultures
indicates that significant myofiber hypertrophy occurs after 5 days
in the presence of 5 x 10 .7 g/ml IGF-I but not IGF-2 (Figure 8).
Morphometric measurement of the mean myofiber diameter confirms
this conclusion (Figure 9). IGF-1 stimulates mean myofiber diameter
by 79% (p < .001) after 5 days of incubation and is as effective
in stimulating myofiber hypertrophy as high concentrations of
insulin (60%, P < .001).
IGF-l-induced muscle growth results from long term stimulation
of protein synthesis rates (Figure i0) and inhibition of protein
degradation rates (Figure ii). IGF-2 at high concentrations also
stimulates protein synthesis rates (Figure i0) and inhibits protein
degradation rates (Figure Ii) but is much less potent than IGF-I.
IGF-I at I0 -_ g/ml stimulates protein synthesis by 62% (P < .01) and
IGF-2 is 2.6 x less effective (24% increase, P < .03). IGF-i or
IGF-2 at 2.5 x i0 -_ g/ml reduces total protein degradation rates by
28% (P < .001) and 9% (P < .02), respectively, after 3 days of
incubation (Figure Ii) based, on calculation of mean protein half
lives from the slopes of the degradation curves in Figure ii. IGF-
1 is thus 3.2 x more effective than IGF-2 in inhibiting protein
degradation. IGF-I is less effective than 85/10/5 in inhibiting
protein degradation during longer term incubations, as is the case
with insulin inhibition of protein degradation (Figure 6B).
00
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DISCUSSION
The major finding in this study is that insulin and IGF-I can
induce rapid and pronounced skeletal myofiber hypertrophy under the
defined conditions of tissue culture. This ability to induce
hypertrophy in vitro results from: I) the development of a new
culture system whereby highly contractile, differentiated myofibers
can be maintained under tension in unsupplemented medium for
extended periods of time; and 2) the development of a serum-free
muscle maintenance medium which contains all the necessary
components for growth factor-induced hypertrophy. Prior to the
developments described in this paper, the analysis of insulin and
insulin-like growth' factor-induced myofiber hypertrophy was
confined to in vivo studies (14,20). Extensive studies of the
anabolic effects of these growth factors on protein turnover have
been performed with organ-cultured skeletal muscle, but even under
the best of conditions (2), these tissues are in negative nitrogen
balance and hypertrophy does not occur. Tissue cultured skeletal
muscle cells have been used to study the short term protein
turnover effects of these growth factors (8,9,10) but the culture
conditions could not sustain long term cell growth leading to
myofiber hypertrophy. These short term studies found that insulin
and IGF-i stimulate protein synthesis (1,I0,17_ and inhibit protein
degradation (10,13,17). Similar results occurred in the present
study, but these alterations in protein turnover are maintained
for 5-7 days and result in pronounced myofiber hypertrophy. The
new model system described in this paper makes it possible to study
all of the mu!ti-f_d steps necessary for myofiber hypertrophy
15
under defined tissue culture conditions.
The hypertrophy response to either insulin or IGF-I in tissue
culture requires high doses of the growth factors. IGF-2, even at
high concentrations, does not stimulate hypertrophy after 5 days
of incubation, even though protein synthesis increases and protein
degradation decreases, as reported previously (10,13), Longer
exposure times in IGF-2 may be necessary to stimulate hypertrophy.
Similar anabolic effects of insulin on tissue cultured skeletal
muscle at supraphysiological levels have been reported by others
(8,11). Numerous possibilities exist for why high concentrations
of insulin are required for growth in vitro. The cells are
metabolically sensitive to physiological insulin concentrations
(Figure I) during the first hours of exposure, but become
insensitive to these levels after 3-4 h of incubation (see
RESULTS). A similar diminished response of cultured myotubes to
insulin stimulated protein synthesis with time has been reported
(i) and may result from the development ef insulin resistance in
the cultured cells (6). High insulin concentrations may overcome
this resistance. Insulin and [GF-I stimulate the synthesis and
secretion of insulin-like growth factor binding proteins in
cultured muscle cells (16) and these proteins may bind and
partially inactivate the anabolic effects of the growth factors
(12). High levels of insulin and IGF-I may be necessary to overcome
this partial inactivation. Other mechanisms may also exist for
inactivation and/or degradation of the growth factors during the
!on_ time p_ds of the experiments V_rformed in the present
study. A third possible reason for the high doses of growth factors
16
needed to stimulate myofiber hypertrophy is the recent finding that
growth factors interact synergistically in stimulating cell growth.
Thus, anabolic steroids potentiate the response of cultured cells,
including skeletal muscle, to IGF-I (5,22). By combining several
different defined growth factors in mmmedium, myofiber hypertrophy
might occur at lower doses of insulin and insulin-like growth
factors. A fourth possibility is that since insulin and insulin-
like growth factors cross react in cultured skeletal muscle with
each other's membrane receptors with varying affinities (21), high
doses of insulin and IGF-I may be required to induce myofiber
hypertrophy because the growth responses are transduced via
receptors of low affinity. Finally, muscle use can dramatically
alter the sensitivity of skeletal muscle to insulin in v[vo (7),
and mechanical stimulation of cultured muscle cel]s may increase
their growth response to more physiological levels of growth
factors (23).
The cultures utilized for the present study contain a mixed
population of postmitotic, multinucleated myofibers and
proliferating, mononucleated cells made up of myoblasts and
fibroblasts. Insulin and IGF-I stimulate both myofiber hypertrophy
and cell proliferation in the mixed cultures, as would be expected
from their known effects on skeletal muscle growth in vivo (7,15)
and in vitro (8,9). The proportion of growth factor induced
changes in protein synthesis and degradation rates in these
different cell populations in the present study are not known;
serum alters both processes to a similar extent ...... _.............
fibroblasts (28,29). Insulin and IGF-I stimulation of hyperplasia
17
may be important in this model system for myofiber growth. Neonatal
to adult myofiber hypertrophy in vivo requires the continued
proliferation and fusion of myogenic cells to already formed
myofibers (19). In vitro the growth factors may stimulate myofiber
hypertrophy by activating myoblasts to proliferate and fuse into
existing myofibers, or they may act directly on the postmitotic
muscle fibers to stimulate their growth. Experiments are in
progress to distinguish between these possibilities.
In summary, cultured skeletal myotubes can be induced by
insulin and insulin-like growth factor-i to undergo rapid and
pronounced hypertrophy under defined culture conditions. This new
model system may assist in studying the second messengers involved
in the hypertrophy response to growth factors and to mechanical
stimulation in vitro.
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FOOTNOTES
I Vandenburgh et al. In Preparation.
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TABLE 1
Insulin's Growth Stimulating Activity at Different Culture Ages
Culture Age Insulin Total Noncollagenous Total DNA
(Days) (i0" M) Protein (_g/well) % (_g/well) %
7-10 - 259.3 ! 8.6 8.6 _ 0.4
+ 339.8 + 9.1" 31% 11.3 Z 0.5"" 31%
m
10-13 - 313.0 ± 5.7 12.5 Z 0.6
+ 397.0 + 5.3" 27% 12.9 ± 0.6 3%
13-16 - , 353.3 ± 2.7 15.0 ± 0.3
+ 433.8 + 6.2" 23% 17.8 _ 0.5"" 19%
Cultures are grown for 7-13 days in complete medium and extensively
rinsed as outlined in MATERIALS AND METHODS before incubation for 3 days in
mm medium ± insulin. Cultures are fed fresh medium every 24 h. Total
noncollagenous protein and DNA are measured as outlined in MATERIALS AND
METHODS. Each value is the mean Z SE of 4 samples and statistical analyses
are by t-tests for unpaired values. "P < .001 "'P < .005
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FIGURE LEGENDS
Figure i. Neonatal _yofibers are metabolically sensitive to
insulin. Myofibers grown for 8 days in complete medium (10% serum,
5% embryo extract), are rinsed extensively and incubated in a serum
free muscle maintenance medium (mm medium) with varying
concentrations of insulin for 4 h (insert) or 24 h. Glucose
utilization is measured after 4 h (Insert) or at 6 h intervals over
a 24 h period (Main Graph) as outlined in MATERIALS AND METHODS.
+ SE of 4 (insert) or 16 (main graph)Each point is the mean _
samples. For the 24 h incubation period, glucose utilization rates
do not change significantly from the first 6 h interval to the
final 6 h interval (data not shown). The data is therefore combined
for the 4 time intervals. Statistical analyses are by t-tests for
unpaired values.
Figure 2. High concentrations of insulin stimulate cell growth.
Muscle cultures are grown as outlined in the legend to Figure 1
and switched to varying insulin concentrations in mm medium on Day
7 postplating. Medium is changed every 24 h. After three days of
incubation total noncollagenous protein (A) and total DNA (B)
content are measured as outlined in MATERIALS AND METHODS. Each
point is the mean ± SE of 4 samples and statistical analyses are
by t-tests for either unpaired values (A), or paired values for
samples from i0-' to i0 -_ M insulin (B).
FI ,-_:.;_<: 2 ...... _,_._ .__,_,_.._, n conc_,2ntrat '- _ ........... _.......
Myofibers are grown for five days (Day 7 to Day 12 postplating) in
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+ i0-' M insulin. Medium is changed every 24mm medium containing _
h. The cultures are fixed and immunocytochemically stained with a
monoclonal antibody (EBI65) against fast embryonic avian myosin
heavy chain. Day 12 cultures in the absence (A,C) or presence (B,D)
of I0-' M insulin. At the higher magnification (C,D), the myofibers
are seen to be well striated. Striations are more difficult to
resolve in the cells grown in 10.5 M insulin because of their
greater thickness. Bar equals 25 _m in A,B and 15 _m in C,D.
Figure 4. Insulin induces myofiber hypertrophy. Mean minimal
myofiber cross sectional diameters are measured in thin sections
as outlined in MATERIALS AND METHODS on cultures treated for 5 to
7 days in mm medium with or without I0 -_ M insulin starting at Day
7 (left) or Day 14 (right) postplating. Each bar represents 28-30
measurements ± SE in randomly chosen thin sections made by three
independent observers and statistical analyses of the combined data
are by t-tests for unpaired samples of no insulin versus i0 -_ M
insulin.
Figure 5. Insulin stimulates long-term protein synthesis rates. Day
7 to 8 muscle cultures are grown as outlined in the legend to
Figure 1 and switched to mm medium containing varying insulin
concentrations for either 3 days (A) or 6 days (B). The medium is
changed every 24 h. Protein synthesis rates are measured during a
4 h incubation at the end of these times as outlined in MATERIALS
' _ L _ _ _1 _ _n_
AND METHODS. Each point is _,,e mean _ _ ..... 4 ....._.......
statistical analyses are by t-tests for unpaired values. Error bars
are smaller than symbol size where not shown.
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Figure 6. Insulin inhibits long-term protein deqradat_on rates.
Day 7 to 8 muscle cultures are grown as outlined in the legend to
Figure 1 and switched to mm medium containing no supplements, i0-'
M insulin, or 85/10/5 medium for either 1 day (A) or 6 days (B).
The medium is replaced every 24 h. Cell proteins are labelled with
_4C-phenylalanine for 20 to 24 h as outlined in MATERIALS AND
METHODS starting on either Day 7 to 8 (A) or Day 13 (B). The
labelled cells are rinsed for 2 h and the efflux of trichloroacetic
acid soluble radioactivity is measured in the medium over a 32 h
period. Each point is the mean ± SE of 4 values and statistical
analyses are by t-tests for unpaired value. Error bars are smaller
than symbol size where not shown.
Figure 7. IGF-I and TGF-2 stimulate muscle cell growth. Muscle
cultures are grown as outlined in the legend to Figure 1 and
switched to varying IGF-I or IGF-2 concentrations in mm medium for
three days starting 7 to I0 days postplating before measuring total
noncollagenous protein (A) and total DNA (B) content as outlined
in MATERIALS AND METHODS. Medium is changed every 24 h. Each point
is the mean Z SE of 4 samples and statistical analyses are by tests
for unpaired values.
Figure 8. IGF-I but not IGF-2 stimulates neonatal myofiber growth.
_' ' _,,e same _ - - _ ",ls experiment Is _utlined in the legpnd to Fi(]ure 3
Control myofibers grown in mm medium without supplements are shown
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in Figure 3A. Myofibers grown for 5 days in 2.5 x i0 -_ g/ml of
either IGF-I (A) or IGF-2 (B) are shown in this Figure. Medium is
changed every 24 h. Bar equal 25 _m.
Figure 9. IGF-I but Dot _GF-2 induces neonatal myofiber
hypertrophy. This experiment is similar to that outlined in the
legend to Figure 4 with 2.5 x i0-' g/ml IGF-I or IGF-2 added in mm
medium at Day 7 postplating and the cultures fixed and stained on
Day 12 postplating. Each bar represents 18-27 measurements ± SE on
whole mounts in randomly chosen sections as outlined in MATERIALS
AND METHODS by two independent observers and statistical analyses
are by t-tests for unpaired samples of the combined data.
Figure I0. IGF-I and IGF-2 stimulate long-term protein synthesis
rates. Day 7 to 8 myofiber cultures are grown as outlined in the
legend to Figure 1 and switched to mm medium contains varying
concentrations of either IGF-I or IGF-2 for 3 days. The medium is
changed every 24 h. Protein synthesis rates are measured during a
4 h incubation at the end of the 3 days as outlined in MATERIALS
+ SE of 4 samples andAND METHODS. Each point is the mean _
statistical analyses are by t-tests for unpaired values (IGF-I) or
paired values (IGF-2, data combined from 1.0 x I0 -_ to 2.5 x i0 -_
g/ml). Error bars are smaller than symbol size where not shown.
Figure Ii. [GF-I and [GF-2 inhibit long-term protein degradation
rates. Day 7 to S muscle cultures are grown as outlined in the
legend to Figure 1 and switched to medium containing 2.5 x i0 -_ g/ml
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IGF-I or IGF-2 for 5 days. The medium is changed every 24 h. Cell
proteins are labelled with 1'C-phenylalanine for 20 to 24 h on Day
i0 to ii and protein degradation measured from Days ii to 12 as
outlined in MATERIALS AND METHODS. Each point is the mean ± SE of
4 values and statistical analyses are by t-tests for unpaired
samples. Error bars are smaller than symbol size where not shown.
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